Incidence of serious gastrointestinal events among tildrakizumab-treated patients with moderate to severe plaque psoriasis: Data from 3 randomized clinical trials Meeting Abstract

sustainable development goals

publication date

  • May 1, 2019

webpage

published in

start page

  • 63

end page

  • 63

volume

  • 60